Important Medicine Safety Information_The risk of acute tubulointerstitial nephritis (TIN) associated with proton pump inhibitors (PPIs)

Important Medicine Safety Information_Golimumab SIMPONI® 50 mg: Important Changes to the Instructions For Use (IFU) for the SmartJect® Autoinjector/Pre-filled Pen

Important Medicine Safety Information_IMBRUVICA® (IBRUTINIB) - RISK OF FATAL CARDIAC EVENTS

Important Medicines Safety Information_COVID-19 Vaccine Janssen 26 October 2021

Important Announcement: IMBRUVICA